Anton Vonk Noordegraaf (Amsterdam, Netherlands), H. Ardeschir Ghofrani (Giessen, Germany)
Prevalence of pulmonary hypertension in a large cohort of patients with hereditary hemorrhagic telangiectasia Veronique Vorselaars (Nieuwegein, Netherlands), Veronique M.M. Vorselaars, Sebastiaan Velthuis, Marco W.F. Van Gent, Cornelis J.J. Westermann, Repke J. Snijder, Johannes J. Mager, Martijn C. Post
| |
Is survival in patients with severe group 3 pulmonary hypertension influenced by targeted therapy? Tobias Lange (Regensburg, Germany), Tobias Lange, Michael Arzt, Michael Pfeifer
| |
Calculation of REVEAL scores for patients with PAH receiving riociguat in the PATENT-2 study Raymond Benza (Pittsburgh, United States of America), Raymond Benza, Adaani Frost, Harrison Farber, Hossein-Ardeschir Ghofrani, Miguel Angel Gómez Sánchez, David Langleben, Stephan Rosenkranz, Dennis Busse, Christian Meier, Sylvia Nikkho, Marius Hoeper
| |
Effect of riociguat on pulmonary arterial compliance (PAC) in patients with PAH in PATENT-1 Ioana Preston (Boston, United States of America), Ioana Preston, Nadine Al-Naamani, Stefano Ghio, Hossein-Ardeschir Ghofrani, Paul Hassoun, Sylvia Nikkho, Arno Fritsch, Adam Torbicki
| |
Metabolic, cardiovascular and gas exchange abnormalities during activities of daily life in patients with idiopathic pulmonary arterial hypertension Jaquelina Sonoe Ota Arakaki (Sao Paulo, Brazil), Melline Almeida, Roberta Ramos, Eloara Ferreira, Ivan Ivanaga, Gabriela Figliolino, Jose Roberto Jardim, Oliver Nascimento, Luiz Eduardo Nery, Jaquelina Ota-Arakaki
| |
An epidemiological study of pulmonary arterial hypertension in Japan Yasunori Kasahara (Chiba, Japan), Yasunori Kasahara, Seiichiro Sakao, Nobuhiro Tanabe, Koichiro Tatsumi
| |
Follow-up of the pulmonary right-to-left shunt with transthoracic contrast echocardiography in patients with hereditary haemorrhagic telangiectasia Veronique Vorselaars (Nieuwegein, Netherlands), Veronique M.M. Vorselaars, Sebas Velthuis, Repke J. Snijder, Cornelis J.J. Westermann, Jan-Albert Vos, Johannes J. Mager, Marco C. Post
| |
Apelin improves cardiac output in patients with pulmonary arterial hypertension Lauren Brash (Glasgow, United Kingdom), Lauren Brash, Gareth Barnes, Melanie Brewis, Colin Church, Simon Gibbs, Luke Howard, Martin Johnson, Neil McGlinchey, Joanne Simpson, Colin Stirrat, Stephen Thomson, Geoffrey Watson, David Welsh, Martin Wilkins, David Newby, Andrew Peacock
| |
Capillary–hemangiomatosis like lesions in the lungs of sickle cell anemia patients Bianca Araujo (SAO PAULO/SP, Brazil), German Rasse, Bianca Bergamo de Araujo Paulino, Guilherme Hencklain, Sandra Menosi, Vera Demarchi, Rogerio Souza, Thais Mauad
| |
Diagnosis of pulmonary hypertension from MR image based computational models of pulmonary vascular haemodynamics and decision tree analysis Angela Lungu (Sheffield, United Kingdom), Angela Lungu, Andrew Swift, Dave Capener, David Kiely, Rod Hose, Jim Wild
| |
Rationale and study design of the RESPITE trial: Riociguat clinical effects studied in pulmonary arterial hypertension (PAH) patients with insufficient treatment response to PDE-5 inhibitors (PDE-5i) Marius M. Hoeper (Hannover, Germany), Marius Hoeper, Raymond Benza, Gerald Simonneau, James Klinger, David Langleben, Robert Naeije, Paul Corris
| |
Pharmacokinetics and safety of concomitant macitentan and hormonal contraceptives Noémie Hurst (Allschwil, Switzerland), Noémie Hurst, Matthias Pellek, Patricia N. Sidharta, Jasper Dingemanse
| |
Anxiety and depression are highly prevalent in pulmonary hypertension and might improve with target therapy Gina Somaini (Zurich, Switzerland), Gina Somaini, Elisabeth Hasler, Sévérine Müller-Mottet, Lars Huber, Rudolf Speich, Konrad Bloch, Silvia Ulrich
| |
Screening pulmonary hypertension by lung doppler signal: A proof-of-concept study Laurent Godinas (Yvoir, Belgium), Laurent Godinas, Frédéric Lador, Rachel Schatzberger, Majd Zreik, Sven Gunther, Michael Segel, Yoram Palti, Olivier Sitbon, Gérald Simonneau
| |
Safety and tolerability of rapid dose-titration of subcutaneous (SC) treprostinil in pulmonary arterial hypertension (PAH) Ekkehard Grünig (Heidelberg, Germany), Ekkehard Grünig, Benjamin Egenlauf, Tobias J. Lange, Ulrich Krüger, Rob Grover, Michelle Pernow, Andrew Traube, Thomas Viethen, Stephan Rosenkranz
| |
Pulmonary hypertension in renal dialysis patients - A matter of water Frank Reichenberger (Gauting, Germany), Julia Ortwein, Andreas Feustel, Henning Gall, Christian Tanislav, Werner Seeger, Hossein Ghofani, Frank Reichenberger
| |
Disease-targeted treatment improves cognitive function in patients with pulmonary hypertension Gina Somaini (Zurich, Switzerland), Gina Somaini, Adriana Stamm, Sévérine Müller-Mottet, Elisabeth Hasler, Keusch Stephan, Hildenbrand Florian, Rudolf Speich, Michael Furian, Konrad Bloch, Silvia Ulrich
| |
Clinical meaning of low DLCO in idiopathic pulmonary arterial hypertension (IPAH) - Prospective single centre study Aneta Kacprzak (Warsaw, Poland), Aneta Kacprzak, Monika Szturmowicz, Monika Franczuk, Barbara Burakowska, Marcin Kurzyna, Anna Fijalkowska, Agnieszka Skoczylas, Stefan Wesolowski, Jan Kus, Adam Torbicki
| |